Nano Labs Ltd Total Liabilities
Nano Labs Ltd total liabilities. Based on the latest financial reports, Nano Labs Ltd (NA) has total liabilities worth $351.10 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Nano Labs Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nano Labs Ltd (2019–2025)
Total liabilities of Nano Labs Ltd from 2019 to 2025. This chart illustrates how Nano Labs Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Nano Labs Ltd (NA) long-term investment share to see how much of total assets are deployed in long-term investments.
Nano Labs Ltd Competitors by Total Liabilities
The table below lists competitors of Nano Labs Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
VirTra Inc
NASDAQ:VTSI
|
USA | $22.08 Million |
|
Biohit Oyj B
HE:BIOBV
|
Finland | €4.90 Million |
|
Chiu Ting Machinery Co Ltd
TW:1539
|
Taiwan | NT$636.03 Million |
|
Uniti SA
PA:ALUNT
|
France | €284.01 Million |
|
Lotus Resources Ltd
AU:LOT
|
Australia | AU$43.91 Million |
|
Pyung Hwa Ind
KO:090080
|
Korea | ₩189.78 Billion |
|
Dogwood Therapeutics, Inc.
NASDAQ:DWTX
|
USA | $14.61 Million |
|
Vivid Seats Inc
NASDAQ:SEAT
|
USA | $793.88 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Nano Labs Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nano Labs Ltd asset portfolio.
Liquidity & Leverage Metrics
Nano Labs Ltd Total Liabilities Ratios Explained
Nano Labs Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nano Labs Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nano Labs Ltd (2019–2025)
The table below shows the annual total liabilities of Nano Labs Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $378.85 Million | -1.09% |
| 2024-12-31 | $383.03 Million | +4.49% |
| 2023-12-31 | $366.56 Million | +80.73% |
| 2022-12-31 | $202.83 Million | -78.30% |
| 2021-12-31 | $934.49 Million | +749.43% |
| 2020-12-31 | $110.01 Million | +234.32% |
| 2019-12-31 | $32.91 Million | -- |
About Nano Labs Ltd
Nano Labs Ltd engages in the design and sale of fabless integrated circuit and product solutions in the People's Republic of China, Hong Kong, Singapore, the United States, and internationally. The company develops HTC chips and HPC chips. It offers Cuckoo 1.0, Cuckoo 2.0, and Cuckoo 3.0 which target the ASIC-resistant mining algorithms of cryptocurrencies, such as Ethereum Classic and Grin; and … Read more